The structure of the pharmaceutical market in Iran using concentration indices

Journal Title: Electronic Physician - Year 2017, Vol 9, Issue 4

Abstract

BACKGROUND AND OBJECTIVE: The efficiency and function of the pharmaceutical sector, as a vital portion of the health system, have a significant effect on intermediate and final indices of health. In this research, the structure of the pharmaceutical market in Iran was examined through the calculation of concentration indices in 2011. METHODS: In this cross-sectional study, the needed data was gathered from the Food and Drug Administration in the year 2011. Data were analyzed using SPSS software version 20 and Microsoft Office Excel software. Finally, two common measures of market concentration, the Concentration Ratio and the Herfindahl-Hirschman Index, were calculated. RESULTS: The largest and the smallest shares of the industry were 5.57% and 0.01%, respectively. The average industry share was 1.09%. The share range was calculated to be 5.56%. The Herfindahl-Hirschman Index was 248.5, which indicates a very low concentration of the pharmaceutical market in Iran. Also, based on the Concentration Ratio of 4 companies (18.39%), the concentration of the pharmaceutical market has been too low. CONCLUSION: The pharmaceutical market in Iran has a very low concentration and it does not have an exclusive mode in terms of market structure. Therefore, it can be attributed to the competitive model. The policy makers in this area can use this characteristic as a leverage to improve efficiency, fairness, revenue and health indices

Authors and Affiliations

Mohammad Mohseni, Hasan Abolghasem Gorji, Bahman Ahadinezhad, Omid Khosravizadeh, Meysam Safi Keykaleh, Ahmad Moosavi, Bahareh Mohtashamzadeh

Keywords

Related Articles

Hospitals’ Readiness for Clinical Governance Implementation in Educational Hospitals of Yazd, Iran

Introduction: Clinical governance is a systematic approach to maintaining and improving the quality of patient care. This study aimed to assess some Iranian educational hospitals’ readiness for clinical governance implem...

Association between Hepatitis G and Unknown Chronic Hepatitis.

Hepatitis G virus (HGV) is a hepatotrope virus with unknown importance. The genome of the virus has been detected in patients with acute or chronic non-A-E hepatitis, cirrhosis, and hepatocellular carcinoma. The aim of t...

A prospective study of psychomotor performance of driving among two kinds of shift work in Iran

BACKGROUND AND AIM: Driving after a night shift imposes a risk on health care professionals and other road users. The aim of this study was to measure psychomotor performance of driving of night shift nurses compared to...

The link between bone disease and cardiovascular complications in hemodialysis patients

INTRODUCTION: The burden on the cardiovascular system is the main cause of mortality in chronic renal patients, and bone disease, which also may cause disability, is one of the most important complications in those patie...

Prevalence of smoking in northwest Iran: a meta-analysis

Background: Tobacco addiction is a major cause of preventable death worldwide. Thus, efforts to eliminate its use have the potential of producing significant health benefits. The purpose of this study was to conduct a me...

Download PDF file
  • EP ID EP320784
  • DOI 10.19082/4251
  • Views 101
  • Downloads 0

How To Cite

Mohammad Mohseni, Hasan Abolghasem Gorji, Bahman Ahadinezhad, Omid Khosravizadeh, Meysam Safi Keykaleh, Ahmad Moosavi, Bahareh Mohtashamzadeh (2017). The structure of the pharmaceutical market in Iran using concentration indices. Electronic Physician, 9(4), 4251-4254. https://europub.co.uk/articles/-A-320784